フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-6 REGISTRATION...
333-187578 SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
Elekta to bring cancer treatment to millions in Africa Elekta's Ian Alexander says current lack of treatment is "totally...
Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting Cloud-based solution allows physicians to harness radiosurgery big data PR...
Elekta helps raise $33,000 to bring radiation treatment to developing countries Fundraising activities at ESTRO to support nonprofit...
New Leksell Gamma Knife to benefit more patients with brain disease Elekta introduces latest in cranial radiosurgery at 3rd ESTRO Forum PR...
Elekta to launch Elekta Healthcare Analytics at HIMSS15 meeting PR Newswire CHICAGO, April 10, 2015 CHICAGO, April 10, 2015 /PRNewswire/ -- HIMSS...
Elekta plans to introduce MRI-guided radiation therapy system in 2017 "Game-changing" technology discussed at University Medical Center...
Australian presence of Elekta's Versa HD radiation therapy system grows Two centers treating patients, one preparing for clinical start-up PR...
Elekta Flexitron brachytherapy treatment delivery available in China China Food and Drug Administration (CFDA) approves cancer treatment...
Elekta technology virtually eliminates MEG helium refills Company debuts work-in-progress helium recycler for Elekta Neuromag® TRIUX™ MEG system...
Elekta donates USD 35,000 to prostate cancer research Employees grow moustaches and raise money for Movember campaign PR Newswire ATLANTA, Dec...
Avera Health partners with Elekta to deliver most advanced cancer care PR Newswire ATLANTA, Dec. 4, 2014 ATLANTA, Dec. 4, 2014 /PRNewswire/ -- To...
Automated beam gating now available with Elekta's Clarity soft tissue visualization system Elekta receives FDA 510(k) clearance for Response...
Elekta's MOSAIQ oncology information system ranks number one in KLAS Oncology 2014 report PR Newswire ATLANTA, Oct. 24, 2014 ATLANTA, Oct. 24...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約